Aspire Biopharma Holdings, Inc. (ASBP) Earnings History
Annual and quarterly earnings data from 2022 to 2024
Loading earnings history...
EPS Growth Rates (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
Download Data
Export ASBP earnings history in CSV or JSON format
Free sign-in required to download data
Aspire Biopharma Holdings, Inc. (ASBP) Earnings Overview
As of March 5, 2026, Aspire Biopharma Holdings, Inc. (ASBP) reported trailing twelve-month net income of -$32M. The company earned $-0.64 per diluted share over the past four quarters.
Looking at the long-term picture, ASBP's historical earnings data spans multiple years. The company achieved its highest annual net income of -$359,071 in fiscal 2023.
Aspire Biopharma Holdings, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to industry peers including CAI (-$538M net income, -0.7% margin), VCYT ($66M net income, 0.1% margin), ADPT (-$80M net income, -0.9% margin), ASBP has comparable earnings metrics. Compare ASBP vs CAI →
Peer Comparison
Earnings metrics vs industry competitors
Historical Data
3 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$13M | -3391.6% | -$3M | $-0.26 | - | - |
| 2023 | $-359,071 | +39.9% | $-358,590 | $-0.01 | - | - |
| 2022 | $-597,117 | - | $-596,491 | $-0.01 | - | - |
See ASBP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ASBP Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare ASBP vs LLY
See how ASBP stacks up against sector leader Eli Lilly and Company.
Start ComparisonFrequently Asked Questions
Is ASBP growing earnings?
ASBP TTM EPS: $-0.64. Net income: $-32M. Earnings growth: N/A.
What are ASBP's profit margins?
Aspire Biopharma Holdings, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are ASBP's earnings?
ASBP earnings data spans 2022-2024. The current earnings trend is N/A YoY. Historical data enables comparison across business cycles.